Trial Profile
A Phase 3, Multicenter, Placebo-controlled, Double-blind, Randomized Study to Compare the Efficacy and Safety of AR01 Otic Solution to a Placebo Solution for Relief of Pain in Acute Otitis Media Subjects Aged 2 Months to 19 Years
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs Benzocaine (Primary)
- Indications Earache
- Focus Registrational; Therapeutic Use
- Sponsors Arbor Pharmaceuticals
- 23 Jun 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 07 Mar 2014 New trial record